2 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Immunwork, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of TE-8105 in Overweight or Obesity Participants TE-8105 MAD Cohort 1, TE-8105 MAD Cohort 2, TE-8105 MAD Cohort 3 - Overweight and Obesity | Phase 2 | Not yet recruiting | Immunwork, Inc. | 204 | 2026-10-01 | 2026-10-05 |
| A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes TE-8105 SAD Cohort 1, TE-8105 SAD Cohort 3, TE-8105 SAD Cohort 5 (Adaptive cohort) - Overweight and Obesity | Phase 1 / Phase 2 | Completed | Immunwork, Inc. | 38 | 2024-07-09 | 2026-01-09 |
| A Phase 1 Study of TE-8214 Solution in Healthy Volunteers TE-8214 - SAD, Placebo - Acromegaly | Phase 1 | Completed | Immunwork, Inc. | 32 | 2024-06-18 | 2025-05-20 |
Obesity (2) · Overweight (2) · Acromegaly (1)
Australia (3)